Jerry S. Lanchbury's Insider Trades & SAST Disclosures
Jerry S. Lanchbury's most recent trade in Myriad Genetics, Inc. was a trade of 6,470 Common Stock done at an average price of $30.9 . Disclosure was reported to the exchange on Oct. 9, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jerry S. Lanchbury.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.88 per share. | 09 Oct 2021 | 6,470 | 264,324 (0%) | 0% | 30.9 | 199,794 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.88 per share. | 09 Oct 2021 | 4,341 | 270,794 (0%) | 0% | 30.9 | 134,050 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.31 per share. | 23 Sep 2021 | 9,747 | 278,768 (0%) | 0% | 33.3 | 324,673 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.31 per share. | 23 Sep 2021 | 3,633 | 275,135 (0%) | 0% | 33.3 | 121,015 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 35.06 per share. | 23 Sep 2021 | 200 | 288,515 (0%) | 0% | 35.1 | 7,012 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2021 | 58,398 | 288,715 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.81 per share. | 25 Aug 2021 | 2,233 | 230,317 (0%) | 0% | 34.8 | 77,731 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 40,000 | 30,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 35.07 per share. | 23 Aug 2021 | 40,000 | 232,550 (0%) | 0% | 35.1 | 1,402,800 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.07 per share. | 23 Aug 2021 | 40,000 | 272,550 (0%) | 0% | 27.1 | 1,082,800 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 30,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 35.57 per share. | 23 Aug 2021 | 30,000 | 232,550 (0%) | 0% | 35.6 | 1,067,100 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.07 per share. | 23 Aug 2021 | 30,000 | 262,550 (0%) | 0% | 27.1 | 812,100 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.07 per share. | 23 Aug 2021 | 10,000 | 242,550 (0%) | 0% | 27.1 | 270,700 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 10,000 | 70,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 35.57 per share. | 23 Aug 2021 | 10,000 | 232,550 (0%) | 0% | 35.6 | 355,700 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 35.57 per share. | 05 Aug 2021 | 28,225 | 232,550 (0%) | 0% | 35.6 | 1,004,008 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2021 | 28,225 | 80,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.07 per share. | 05 Aug 2021 | 28,225 | 260,775 (0%) | 0% | 27.1 | 764,051 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.07 per share. | 03 Aug 2021 | 38,225 | 270,775 (0%) | 0% | 27.1 | 1,034,751 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 38,225 | 120,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 35.24 per share. | 03 Aug 2021 | 38,225 | 232,550 (0%) | 0% | 35.2 | 1,347,171 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 27,830 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 03 Aug 2021 | 27,830 | 232,550 (0%) | 0% | 34 | 946,220 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.98 per share. | 03 Aug 2021 | 27,830 | 260,380 (0%) | 0% | 24.0 | 667,363 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 16,225 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 33.99 per share. | 03 Aug 2021 | 16,225 | 232,550 (0%) | 0% | 34.0 | 551,488 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.49 per share. | 03 Aug 2021 | 16,225 | 248,775 (0%) | 0% | 26.5 | 429,800 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 11,775 | 108,225 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 35.57 per share. | 03 Aug 2021 | 11,775 | 232,550 (0%) | 0% | 35.6 | 418,856 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.07 per share. | 03 Aug 2021 | 11,775 | 244,325 (0%) | 0% | 27.1 | 318,749 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 4,170 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.98 per share. | 03 Aug 2021 | 4,170 | 236,720 (0%) | 0% | 24.0 | 99,997 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 03 Aug 2021 | 4,170 | 232,550 (0%) | 0% | 34 | 141,780 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 1,775 | 158,225 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 35.07 per share. | 03 Aug 2021 | 1,775 | 232,550 (0%) | 0% | 35.1 | 62,249 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.07 per share. | 03 Aug 2021 | 1,775 | 234,325 (0%) | 0% | 27.1 | 48,049 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.49 per share. | 12 Jul 2021 | 40,000 | 272,550 (0%) | 0% | 26.5 | 1,059,600 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 33.74 per share. | 12 Jul 2021 | 40,000 | 232,550 (0%) | 0% | 33.7 | 1,349,756 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2021 | 40,000 | 16,225 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.49 per share. | 12 Jul 2021 | 36,705 | 269,255 (0%) | 0% | 26.5 | 972,315 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 33.55 per share. | 12 Jul 2021 | 36,705 | 232,550 (0%) | 0% | 33.5 | 1,231,431 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2021 | 36,705 | 72,815 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.49 per share. | 12 Jul 2021 | 13,295 | 245,845 (0%) | 0% | 26.5 | 352,185 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 33.55 per share. | 12 Jul 2021 | 13,295 | 232,550 (0%) | 0% | 33.6 | 446,075 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2021 | 13,295 | 59,520 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2021 | 3,295 | 56,225 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.49 per share. | 12 Jul 2021 | 3,295 | 235,845 (0%) | 0% | 26.5 | 87,285 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 33.69 per share. | 12 Jul 2021 | 3,295 | 232,550 (0%) | 0% | 33.7 | 111,012 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.49 per share. | 09 Jul 2021 | 26,705 | 259,255 (0%) | 0% | 26.5 | 707,415 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2021 | 26,705 | 115,123 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.79 per share. | 09 Jul 2021 | 26,705 | 232,550 (0%) | 0% | 32.8 | 875,657 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2021 | 17,692 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.47 per share. | 09 Jul 2021 | 17,692 | 232,550 (0%) | 0% | 32.5 | 574,459 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.47 per share. | 09 Jul 2021 | 17,692 | 250,242 (0%) | 0% | 19.5 | 344,463 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2021 | 5,603 | 109,520 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.29 per share. | 09 Jul 2021 | 5,603 | 232,550 (0%) | 0% | 32.3 | 180,921 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.49 per share. | 09 Jul 2021 | 5,603 | 238,153 (0%) | 0% | 26.5 | 148,423 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.29 per share. | 07 Jul 2021 | 30,424 | 232,550 (0%) | 0% | 32.3 | 982,391 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2021 | 30,424 | 141,828 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.49 per share. | 07 Jul 2021 | 30,424 | 262,974 (0%) | 0% | 26.5 | 805,932 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2021 | 1,884 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.99 per share. | 07 Jul 2021 | 1,884 | 232,550 (0%) | 0% | 32.0 | 60,269 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.49 per share. | 07 Jul 2021 | 1,884 | 234,434 (0%) | 0% | 26.5 | 49,907 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.43 per share. | 28 Jun 2021 | 3,973 | 232,550 (0%) | 0% | 32.4 | 128,855 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 3,973 | 172,252 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.49 per share. | 28 Jun 2021 | 3,973 | 236,523 (0%) | 0% | 26.5 | 105,245 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 1,891 | 1,884 | - | - | Incentive Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.23 per share. | 28 Jun 2021 | 1,891 | 232,550 (0%) | 0% | 32.2 | 60,950 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.49 per share. | 28 Jun 2021 | 1,891 | 234,441 (0%) | 0% | 26.5 | 50,093 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 948 | 17,692 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.49 per share. | 28 Jun 2021 | 948 | 232,550 (0%) | 0% | 32.5 | 30,804 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.47 per share. | 28 Jun 2021 | 948 | 233,498 (0%) | 0% | 19.5 | 18,458 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.61 per share. | 25 Jun 2021 | 33,372 | 232,550 (0%) | 0% | 31.6 | 1,055,036 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2021 | 28,640 | 18,640 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.97 per share. | 25 Jun 2021 | 28,640 | 265,922 (0%) | 0% | 32.0 | 915,621 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.47 per share. | 25 Jun 2021 | 28,640 | 294,562 (0%) | 0% | 19.5 | 557,621 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.47 per share. | 25 Jun 2021 | 21,360 | 265,922 (0%) | 0% | 32.5 | 693,559 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2021 | 21,360 | 47,280 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.47 per share. | 25 Jun 2021 | 21,360 | 287,282 (0%) | 0% | 19.5 | 415,879 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.47 per share. | 04 May 2021 | 19,360 | 285,282 (0%) | 0% | 19.5 | 376,939 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2021 | 19,360 | 68,640 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.97 per share. | 04 May 2021 | 19,360 | 265,922 (0%) | 0% | 32.0 | 618,949 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.47 per share. | 27 Apr 2021 | 40,000 | 265,922 (0%) | 0% | 31.5 | 1,258,800 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2021 | 40,000 | 88,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.47 per share. | 27 Apr 2021 | 40,000 | 305,922 (0%) | 0% | 19.5 | 778,800 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 19,347 | 265,922 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 29.71 per share. | 16 Feb 2021 | 74,445 | 246,575 (0%) | 0% | 29.7 | 2,211,992 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 16 Feb 2021 | 74,445 | 321,020 (0%) | 0% | 18 | 1,340,010 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 74,445 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 5,555 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 29.71 per share. | 16 Feb 2021 | 5,555 | 246,575 (0%) | 0% | 29.7 | 165,056 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 16 Feb 2021 | 5,555 | 252,130 (0%) | 0% | 18 | 99,990 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2020 | 39,196 | 246,575 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 13.04 per share. | 30 Sep 2020 | 5,544 | 207,379 (0%) | 0% | 13.0 | 72,294 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 32,800 | 226,308 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 12.44 per share. | 24 Sep 2020 | 5,544 | 220,764 (0%) | 0% | 12.4 | 68,967 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 12.44 per share. | 24 Sep 2020 | 4,214 | 216,550 (0%) | 0% | 12.4 | 52,422 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 12.44 per share. | 24 Sep 2020 | 3,627 | 212,923 (0%) | 0% | 12.4 | 45,120 | Common Stock |
| Myriad Genetics, Inc. | Jerry S. Lanchbury | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2020 | 10,068 | 193,508 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges